Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics has resolved to convene its 15th Annual General Meeting of Shareholders on March 20 to vote on agenda items including financial statement approval, articles of incorporation amendments, and director appointments.
📊 [Key Disclosure Details & Financial Figures]
- Meeting Type: 15th Annual General Meeting of Shareholders (AGM)
- Date & Time: March 20, 2026 at 09:00 AM (KST)
- Location: Room 305, 3rd Floor, Songdo Convensia, 123 Central-ro, Yeonsu-gu, Incheon, South Korea
- Board Resolution Date: February 11, 2026 (4 outside directors attended, 0 absent)
- Main Agenda Items:
- Reported Items: Report on transactions with related parties, Audit report, Business report, Report on the operation status of internal accounting control system
- Voting Items:
- Agenda Item 1: Approval of Financial Statements for the 15th Term (FY2025: Jan 1, 2025 – Dec 31, 2025)
- Agenda Item 2: Amendments to Articles of Incorporation (Item 2-1: Reorganization of exclusion of cumulative voting, Item 2-2: Reflecting Commercial Act amendments)
- Agenda Item 3: Appointment of Directors
- Item 3-1: Re-appointment of Executive Director John Chongbo Rim (3-year term)
- Item 3-2: Re-appointment of Executive Director Gyun Rho (3-year term)
- Agenda Item 4: Appointment of Jung Yeon Kim as an Outside Director Who Will Serve as an Audit Committee Member (Newly appointed, 3-year term)
- Agenda Item 5: Approval of Director Compensation Limit
- Details of Director Nominees:
- John Chongbo Rim (Born Oct 1961): Current President & CEO of Samsung Biologics (Re-appointment, 3-year term)
- Gyun Rho (Born Jan 1963): Current Executive Vice President & Head of EPCV Center at Samsung Biologics (Re-appointment, 3-year term)
- Jung Yeon Kim (Born Oct 1980): Current Professor at Ewha Womans University School of Law (Newly appointed, 3-year term; slated to resign from Hankook Tire & Technology outside director role prior to AGM)
- Other Matters: The above details are subject to change depending on company circumstances.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Confirming AGM Voting Outcomes and Board Election Results
This disclosure convenes the general shareholders meeting to vote on core governance matters, including financial statement approval, director appointments, and charter amendments.
Tracking whether all submitted agenda items are approved as proposed at the meeting is crucial for understanding changes in corporate leadership and the finalization of annual financial results.
The finalized outcomes can be verified in the subsequent ‘Results of General Shareholders Meeting’ disclosure following the meeting date.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
